Shandong Xinhua Pharmaceutical Company Limited announced that Non-Executive Director Xu Lie has resigned from the Board and the Strategic Development Committee effective 31 March 2026, citing retirement due to age.
The company confirmed that Xu Lie has no disagreements with the Board and is unaware of any matters needing shareholder or Hong Kong Stock Exchange attention. Following his departure, Xu Lie no longer holds any position within the group.
Current board composition is as follows:
• Executive Directors: He Tongqing (Chairman), Xu Wenhui, Hou Ning, Cheung Ching Ching, Daisy • Independent Non-executive Directors: Pan Guangcheng, Zhu Jianwei, Ling Peixue • Non-executive Director: Zhang Chengyong
The Board expressed appreciation for Xu Lie’s contributions during his tenure.
Comments